CompanyTrack
L

LARIO THERAPEUTICS LIMITED

Active Edinburgh

Research and experimental development on biotechnology

1 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
L

LARIO THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 26 Nov 2021 Active Edinburgh, United Kingdom 1 employees lariotx.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Sept 2025
Confirmation Statement Submitted 16 Dec 2025
Net assets £-4.79M £1.88M 2024 year on year
Total assets £2.60M £208.94K 2024 year on year
Total Liabilities £7.38M £2.09M 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

137a George Street Edinburgh EH2 4JY United Kingdom

Website

lariotx.com

Credit Report

Discover LARIO THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£1.36M

Increased by £999.24k (+273%)

Net Assets

-£4.79M

Decreased by £1.88M (-65%)

Total Liabilities

£7.38M

Increased by £2.09M (+40%)

Turnover

N/A

Employees

1

Debt Ratio

284%

Increased by 62 (+28%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 657,961 Shares £14.20m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Jun 202538,693£38.693£0.001
14 Mar 2025111,822£3.74m£33.48
14 Mar 202595,786£2.61m£27.2
14 Mar 2025111,822£3.74m£33.48
14 Mar 202595,786£2.61m£27.2

Officers

Officers

3 active 2 resigned
Status
Chiara Rossana Maria LiberatiDirectorItalianItaly551 Jun 2023Active
Henning Klaus-willi Christian SteinhagenDirectorGermanGermany5626 Nov 2021Active
Peter Michael FinanDirectorBritishEngland589 Jul 2024Active

Shareholders

Shareholders (9)

Golgi Neurosciences S.r.l.
23.3%
50,00015 Jan 2024
Henning Steinhagen
5.0%
10,75215 Jan 2024
Rainer Netzer
0.4%
96715 Jan 2024

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Epidarex Capital Iii Uk, Lp

United Kingdom

Active
Notified 28 Mar 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Henning Klaus-willi Christian Steinhagen

Ceased 25 Mar 2022

Ceased

Group Structure

Group Structure

EPIDAREX CAPITAL III UK, LP united kingdom appoint/remove person
EPIDAREX MANAGEMENT LTD united kingdom
BRITISH BUSINESS FINANCE LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
LARIO THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
16 Dec 2025Confirmation StatementConfirmation statement made on 2025-11-25 with updatesView(5 pages)
29 Sept 2025AccountsAnnual accounts made up to 2024-12-31View(12 pages)
14 Aug 2025CapitalAllotment of shares (GBP 461.353) on 2025-06-16View(4 pages)
2 Jul 2025ResolutionResolutionsView(4 pages)
2 Jul 2025IncorporationMemorandum ArticlesView(58 pages)
16 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-11-25 with updates

29 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

14 Aug 2025 Capital

Allotment of shares (GBP 461.353) on 2025-06-16

2 Jul 2025 Resolution

Resolutions

2 Jul 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-25 with updates

2 months ago on 16 Dec 2025

Annual accounts made up to 2024-12-31

4 months ago on 29 Sept 2025

Allotment of shares (GBP 461.353) on 2025-06-16

6 months ago on 14 Aug 2025

Resolutions

7 months ago on 2 Jul 2025

Memorandum Articles

7 months ago on 2 Jul 2025